These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 936381)

  • 21. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
    Collier D; Soloway MS
    Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate.
    Schmidt JD; Scott WW; Gibbons RP; Johnson DE; Prout GR; Loening SA; Soloway MS; Chu TM; Gaeta JF; Slack NH; Saroff J; Murphy GP
    J Urol; 1979 Feb; 121(2):185-9. PubMed ID: 370420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases.
    Eisenkraft S; Huben RP; Pontes JE
    Urology; 1984 Jun; 23(6 Suppl):51-3. PubMed ID: 6539524
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combination cytostatic chemotherapy of advanced metastatic cancer of the prostate. A preliminary uncontrolled study].
    Ogaard S; Jensen TS
    Ugeskr Laeger; 1977 Feb; 139(9):515-7. PubMed ID: 841743
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate.
    Soloway MS; Shippel RM; Ikard M
    J Urol; 1979 Nov; 122(5):637-9. PubMed ID: 501816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prelinimary report on combination therapy for advanced prostatic cancer.
    Merrin C
    Cancer Treat Rep; 1977; 61(2):313-5. PubMed ID: 559544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate.
    Loening SA; Scott WW; deKernion J; Gibbons RP; Johnson DE; Pontes JE; Prout GR; Schmidt JD; Soloway MS; Chu TM; Gaeta JF; Slack NH; Murphy GP
    J Urol; 1981 Jun; 125(6):812-6. PubMed ID: 7017170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
    Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
    Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
    [No Abstract]   [Full Text] [Related]  

  • 29. [Advanced cancer of the prostate: chemotherapy].
    Garcia-Giralt E; Palangie T; Dorval T; Jouve M; Pouillart P
    Bull Cancer; 1986; 73(1):68-73. PubMed ID: 3779125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential polychemotherapy for advanced prostatic carcinoma. A preliminary cooperative study on 30 patients.
    Lachand AT; Garcia-Giralt E; Auvert J; Juraschek F; Mennecier P; Pallangie T; Moustafa T
    Eur Urol; 1979; 5(4):250-1. PubMed ID: 436871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report.
    Johnson DE; Scott WW; Gibbons RP; Prout GR; Schmidt JD; Chu TM; Gaeta J; Saroff J; Murphy GP
    Cancer Treat Rep; 1977; 61(2):317-23. PubMed ID: 141326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclical combination chemotherapy for advanced breast carcinoma.
    Canellos GP; Devita VT; Gold GL; Chabner BA; Schein PS; Young RC
    Br Med J; 1974 Feb; 1(5901):218-20. PubMed ID: 4818162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer.
    Brandes LJ; Bracken SP; Ramsey EW
    J Clin Oncol; 1995 Jun; 13(6):1398-403. PubMed ID: 7751884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cytostatic therapy of prostatic carcinoma. Current status and personal results].
    Nagel R; Leistenschneider W
    Urologe A; 1983 Sep; 22 Suppl():304-9. PubMed ID: 6356555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of advanced prostatic cancer today.
    Murphy GP; Merrin CE
    Prog Clin Biol Res; 1976; 6():285-99. PubMed ID: 139614
    [No Abstract]   [Full Text] [Related]  

  • 36. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of advanced prostate cancer with cyclophosphamide, doxorubicin, and methotrexate.
    Straus MJ; Fleit JP; Engelking C
    Cancer Treat Rep; 1982 Oct; 66(10):1797-802. PubMed ID: 7127321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma.
    Yagoda A
    Cancer; 1973 Nov; 32(5):1131-40. PubMed ID: 4271302
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer.
    Rao B; Wanebo HJ; Ochoa M; Lewis JL; Oettgen HF
    Cancer; 1977 Feb; 39(2):514-26. PubMed ID: 837334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chemotherapy for prostatic carcinoma on T lymphocyte levels.
    Catalona WJ
    J Urol; 1974 Dec; 112(6):802-7. PubMed ID: 4548092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.